Department of Defense August 13, 2008 – Federal Register Recent Federal Regulation Documents

In accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(I)(i), announcement is made of the intent to grant an exclusive, royalty- bearing, revocable license to U.S. Patent No. 6,451,309 entitled ``Prophylactic and Therapeutic Monoclonal Antibodies,'' issued September 17, 2002; and U.S. Patent No. 6,620,412 entitled, ``Prophylactic and Therapeutic Monoclonal Antibodies,'' issued September 16, 2003, which is a continuation of U.S. Patent No. 6,451,309, and foreign rights to BioFactura, Inc., with its principal place of business at 9700 Great Seneca Highway, Rockville, Maryland 20850.